Clinical and Experimental Rheumatology Online Abstracts and full text from 1999 to the present. Only paid subscribers may access the full text of articles published in the last four years. Previous years are free to view.
» select issue no. 0no. 1no. 2no. 3Suppl. 75 » Vasculitis 2013
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 70 » Vasculitis 2012Suppl. 71 » Scleroderma Care and Research - May 2012Suppl. 72 » Behçet's disease and other autoinflammatory conditions - No. 12Suppl. 73 » Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerationsSuppl. 74 » Fibromyalgia and related syndromes 2012
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 64 » Vasculitis 2011Suppl. 65 » Scleroderma Care and Research - May 2011Suppl. 66 » Italian Society for Rheumatology (SIR) guidelines on the use of biologics in rheumatic disSuppl. 67 » Behçet's disease and other autoinflammatory conditions - No. 11Suppl. 68 » Low-dose glucocorticoids in rheumatic diseasesSuppl. 69 » Fibromyalgia and related syndromes 2011
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 57 » Vasculitis 2010Suppl. 58 » Scleroderma Care and Research - June 2010 Suppl. 59 » Evolution of anti-TNF treatment for rheumatoid arthritisSuppl. 60 » Behçet's disease and other autoinflammatory conditions - No. 10Suppl. 61 » Methotrexate in rheumatic diseasesSuppl. 62 » Scleroderma Care and Research - October 2010Suppl. 63 » Fibromyalgia and related syndromes 2010
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 52 » Vasculitis 2009Suppl. 53 » Behçet's disease and other autoinflammatory conditions - No. 9Suppl. 54 » Scleroderma Care and ResearchSuppl. 55 » A Systematic Comparison between Rheumatoid Arthritis and Ankylosing SpondylitisSuppl. 56 » Fibromyalgia and related syndromes 2009
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 48 » Infections, Rheumatism and AutoimmunitySuppl. 49 » Vasculitis 2008Suppl. 50 » Behçet's disease and other autoinflammatory conditions - No. 8Suppl. 51 » Mortality in rheumatic diseases
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 44 » Vasculitis 2007Suppl. 45 » Behçet's disease and other autoinflammatory conditions - No. 7Suppl. 46 » Abatacept: selective T cell co-stimulation modulation in the management of rheumatoid arthSuppl. 47 » Quality of care in rheumatology: opportunities and challenges
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 40 » Skin, Rheumatism and AutoimmunitySuppl. 41 » Vasculitis 2006Suppl. 42 » Behçet's disease and other autoinflammatory conditions - No. 6Suppl. 43 » Remission in rheumatic diseases
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 38 » Behçet's disease and other autoinflammatory conditions - No. 3Suppl. 39 » Quantitative Clinical Assessement of Rheumatic Diseases.
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 33 » Systemic sclerosis. The legacy of a maestroSuppl. 34 » Behçet's disease and familial Mediterranean fever - No. 4Suppl. 35 » Benefit/risk of new drugs for rheumatoid arthritisSuppl. 36 » Vasculitis 2004
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 29 » The assessment of the patient with systemic sclerosis.Suppl. 30 » Behçet's disease and familial Mediterranean fever - No. 3Suppl. 31 » Early arthritisSuppl. 32 » Vasculitis 2003
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 26 » Behçet's disease and familial Mediterranean fever - No. 2Suppl. 27 » IL-1Ra as a new biological approach for the treatment of rheumatoid arthritis.Suppl. 28 » Innovative therapies for the spondyloarthritides
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 22 » Nimesulide: beyond COX-2Suppl. 23 » Quality of life in juvenile idiopathic arthritis patients compared to healthy childrenSuppl. 24 » Behçet's disease and familial Mediterranean fever - No. 1Suppl. 25 » Controversies in COX-2 inhibitor therapy
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 19 » Cervicogenic headacheSuppl. 20 » First International Conference on Polymyalgia Rheumatica/Giant Cell ArteritisSuppl. 21 » Bone mass in the rheumatic diseases
» select issue no. 1no. 2no. 3no. 4no. 5no. 6Suppl. 18 » Combination disease-modifying anti-rheumatic drug therapy in rheumatoid arthritis